Rankings
▼
Calendar
LXRX Q3 2017 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
LXRX
Lexicon Pharmaceuticals, Inc.
$693M
Q3 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$27M
-2.8% YoY
Gross Profit
$26M
97.8% margin
Operating Income
-$30M
-109.6% margin
Net Income
-$31M
-114.0% margin
EPS (Diluted)
$-0.29
QoQ Revenue Growth
+123.5%
Cash Flow
Operating Cash Flow
-$34M
Free Cash Flow
-$34M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$329M
Total Liabilities
$251M
Stockholders' Equity
$78M
Cash & Equivalents
$83M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$27M
$28M
-2.8%
Gross Profit
$26M
-$25M
+206.2%
Operating Income
-$30M
-$35M
+15.5%
Net Income
-$31M
-$36M
+14.7%
← FY 2017
All Quarters
Q4 2017 →